Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

Ning Sun,1,2 Chunxia Yang,1 Xiaoting He,1,3 Zhifen Liu,1 Sha Liu,1 Xinrong Li,1 Yanfang Wang,1 Ruihua Jin,2 Kerang Zhang1 1Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, People’s Republic of China; 2Nursing College of Shanxi Medical University, Taiyuan, Peo...

Full description

Bibliographic Details
Main Authors:	Sun N, Yang C, He X, Liu Z, Liu S, Li X, Wang Y, Jin R, Zhang K
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-06-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	major depressive disorder (mdd) microrna-34c single nucleotide polymorphism cognitive function
Online Access:	https://www.dovepress.com/impact-of-expression-and-genetic-variation-of-microrna-34bc-on-cogniti-peer-reviewed-article-NDT

Similar Items

Underdiagnosis of Major Depressive Episodes in Hemodialysis Patients: The Need for Screening and Patient Education
by: Wojciech Orzechowski, et al.
Published: (2021-09-01)

Sex differences in gut microbiota in patients with major depressive disorder
by: Chen JJ, et al.
Published: (2018-02-01)

SNPs in microRNA target sites and their potential role in human disease
by: Adrianna Moszyńska, et al.
Published: (2017-01-01)

Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder
by: Katarzyna Bialek, et al.
Published: (2020-02-01)

FVC, FEV1 and FEV1/FVC% in patients with Major Depressive Disorder
by: Khandaker Nadia Afreen, et al.
Published: (2016-12-01)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
by: Muhammad Siddique Kakar, et al.
Published: (2020-10-01)

The Impact of Residual Symptoms in Major Depression
by: Joshua A. Israel
Published: (2010-08-01)

Reduced serum VGF levels are linked with suicide risk in Chinese Han patients with major depressive disorder
by: Xingxing Li, et al.
Published: (2020-05-01)

Melanopsin-Driven Pupil Response and Light Exposure in Non-seasonal Major Depressive Disorder
by: Beatrix Feigl, et al.
Published: (2018-09-01)

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population
by: Wang F, et al.
Published: (2020-02-01)

MicroRNA Polymorphisms in Cancer: A Literature Analysis
by: Veronika Pipan, et al.
Published: (2015-09-01)

Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
by: Rachael Horne, et al.
Published: (2018-10-01)

Prediction of single-nucleotide polymorphisms within microRNAs binding sites of neuronal genes related to multiple sclerosis: A preliminary study
by: Reyhaneh Dehghanzad, et al.
Published: (2021-01-01)

MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment
by: Wei-Hong Kuang, et al.
Published: (2018-05-01)

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
by: Katsuki A, et al.
Published: (2019-08-01)

Bioinformatic resources of microRNA sequences, gene targets and genetic variation
by: Wenbo eMu, et al.
Published: (2012-03-01)

Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect
by: Song X, et al.
Published: (2021-08-01)

Single Nucleotide Polymorphisms Associated with MicroRNA Regulation
by: Yu Jin, et al.
Published: (2013-04-01)

Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism
by: Sugarniya Subramaniam, et al.
Published: (2021-07-01)

ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder
by: Milanesi Elena, et al.
Published: (2012-09-01)

Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival
by: Sung Hyuna, et al.
Published: (2012-05-01)

Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
by: Yuhang Huan, et al.
Published: (2021-09-01)

Ketamine exerts a protective role in a cell-based model of major depressive disorder via the inhibition of apoptosis and inflammation and activation of the Krebs cycle
by: Wenfei Zhang, et al.
Published: (2019-06-01)

Is there seasonality in hospitalizations for major depressive disorder in Canada?
by: AISWARYA PILLAI, et al.

The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior
by: Gianluca Serafini, et al.
Published: (2021-12-01)

Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder
by: Md. Rabiul Islam, et al.
Published: (2020-06-01)

Single nucleotide polymorphisms in microRNA binding sites on the HOX genes regulate carcinogenesis: An in-silico approach
by: Waseem El-Huneidi, et al.
Published: (2021-09-01)

Prediction of Probable Major Depressive Disorder in the Taiwan Biobank: An Integrated Machine Learning and Genome-Wide Analysis Approach
by: Eugene Lin, et al.
Published: (2021-06-01)

An Updated Meta-Analysis of the Associations Between MicroRNA Polymorphisms and Susceptibility to Rheumatoid Arthritis
by: Mi Zhou, et al.
Published: (2018-11-01)

Executive Function and Spatial Cognition Mediate Psychosocial Dysfunction in Major Depressive Disorder
by: Matthew J. Knight, et al.
Published: (2018-10-01)

Individualized diagnosis of major depressive disorder via multivariate pattern analysis of thalamic sMRI features
by: Hanxiaoran Li, et al.
Published: (2021-08-01)

Associations between microRNA (miR-25, miR-32, miR-125, and miR-222) polymorphisms and recurrent implantation failure in Korean women
by: Jeong Yong Lee, et al.
Published: (2019-12-01)

The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case–control association study
by: Chenghao Yang, et al.
Published: (2021-09-01)

Gender differences in prevalence and clinical correlates of anxiety symptoms in first-episode and drug-naïve patients with major depressive disorder
by: Wan-Qiu Yang, et al.
Published: (2021-11-01)

Commentary: Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.
by: Eiko I Fried, et al.
Published: (2015-08-01)

Polymorphism of miRNA and esophageal cancer risk: an updated systemic review and meta-analysis
by: Guo X, et al.
Published: (2019-05-01)

Serum 25-Hydroxyvitamin D Concentrations and Major Depression: A Mendelian Randomization Study
by: Karl Michaëlsson, et al.
Published: (2018-12-01)

MicroRNA-146a Is a Wide-Reaching Neuroinflammatory Regulator and Potential Treatment Target in Neurological Diseases
by: Weihao Fan, et al.
Published: (2020-06-01)

Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression
by: Sarah Kittel-Schneider, et al.
Published: (2020-04-01)

Analysis of the Association Between MicroRNA Biogenesis Gene Polymorphisms and Venous Thromboembolism in Koreans
by: Eun Ju Ko, et al.
Published: (2019-08-01)